BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9543218)

  • 1. Characteristics of chronic venous insufficiency in 895 patients followed in general practice.
    Boccalon H; Janbon C; Saumet JL; Tafani A; Roux T; Vilain C
    Int Angiol; 1997 Dec; 16(4):226-34. PubMed ID: 9543218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
    Andreozzi GM
    Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of a venotropic drug in man. Example of Daflon 500 mg.
    Laurent R; Gilly R; Frileux C
    Int Angiol; 1988; 7(2 Suppl):39-43. PubMed ID: 3053942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographic factors and their relationship with the presence of CVI signs in Italy: the 24-cities cohort study.
    Chiesa R; Marone EM; Limoni C; Volonté M; Schaefer E; Petrini O
    Eur J Vasc Endovasc Surg; 2005 Dec; 30(6):674-80. PubMed ID: 16055355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced chronic venous insufficiency is associated with increased calf muscle deoxygenation.
    Yamaki T; Nozaki M; Sakurai H; Soejima K; Kono T; Hamahata A
    Eur J Vasc Endovasc Surg; 2010 Jun; 39(6):787-94. PubMed ID: 20227896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors of chronic venous insufficiency of the lower extremities and possibilities of its medication in therapeutic practice].
    Oganov RG; Savel'ev VS; Shal'nova SA; Kirienko AI; Zolotukhin IA
    Ter Arkh; 2006; 78(4):68-72. PubMed ID: 16821427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Derivatives of semi-synthetic diosmine in the treatment of patients with chronic venous insufficiency. The results of a prospective study--using phlebodia 600].
    Pokrovskiĭ AV; Sapelkin SV
    Angiol Sosud Khir; 2005; 11(4):73-9. PubMed ID: 16474293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Semisynthetic Diosmin (Phlebodia 600) for therapy of lower limb chronic venous insufficiency].
    Kirienko AI; Bogachev VIu; Zolotukhin IA; Golovanova OV
    Angiol Sosud Khir; 2006; 12(2):73-5. PubMed ID: 17053765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assEssment and quaLity of lIfe improvEment with micronized Flavonoids.
    Jantet G
    Angiology; 2002; 53(3):245-56. PubMed ID: 12025911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microcirculation end effect of detralex in patients with chronic venous insufficiency of the lower extremities].
    Sirotin BZ; Zhmerenetskĭ KV
    Angiol Sosud Khir; 2003; 9(3):60-5. PubMed ID: 14657934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A double-blind study comparing the clinical efficacy of the preparation F-117 (hidrosmin) versus diosmin in the treatment of patients with peripheral venous disorders].
    Honorato Pérez J; Arcas Meca R
    Rev Med Univ Navarra; 1990; 34(2):77-9. PubMed ID: 2130425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of clinical efficacy of a venotonic drug: lessons of a therapeutic trial with hemisynthesis diosmin in "heavy legs syndrome"].
    Carpentier PH; Mathieu M
    J Mal Vasc; 1998 Apr; 23(2):106-12. PubMed ID: 9608923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form.
    Cospite M; Dominici A
    Int Angiol; 1989; 8(4 Suppl):61-5. PubMed ID: 2698903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of venous insufficiency in an occupational population.
    Lacroix P; Aboyans V; Preux PM; Houlès MB; Laskar M
    Int Angiol; 2003 Jun; 22(2):172-6. PubMed ID: 12865883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic venous insufficiency--outpatient study of risk factors].
    Musil D; Herman J
    Vnitr Lek; 2004 Jan; 50(1):14-20. PubMed ID: 15015225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of administering Phlebodia 600 in fertile women with orthostasis-dependent phlebopathy].
    Tsukanov IuT; Tsukanov AIu
    Angiol Sosud Khir; 2007; 13(3):107-12. PubMed ID: 18382403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Edema as a measure for severity of chronic venous insufficiency and efficacy of its treatment].
    Sapelkin SV
    Angiol Sosud Khir; 2008; 14(3):79-81. PubMed ID: 19791434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired ambulatory venous function in lymphedema assessed by near-infrared spectroscopy.
    Saito T; Hosoi Y; Onozuka A; Komiyama T; Miyata T; Shigematsu H; Nagawa H
    Int Angiol; 2005 Dec; 24(4):336-9. PubMed ID: 16355090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelvic venous incompetence: reflux patterns and treatment results.
    Asciutto G; Asciutto KC; Mumme A; Geier B
    Eur J Vasc Endovasc Surg; 2009 Sep; 38(3):381-6. PubMed ID: 19574069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency.
    Boyle P; Diehm C; Robertson C
    Int Angiol; 2003 Sep; 22(3):250-62. PubMed ID: 14612852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.